ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,107.20
      -1.02%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.59
      -0.23%
      Bitcoin
      65,847.21
      -0.11%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. UroGen Pharma Ltd (URGN)

      7. UroGen Pharma Ltd (URGN) Financials

      UroGen Pharma Ltd

      UroGen Pharma Ltd (URGN)

      NASDAQ
      16.94
      0.74
      (4.57%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      16.94
      0.00
      (0.00%)
      After Hours: 7:36PM
      Delayed by 15 minutes

      UroGen Pharma Ltd Financial Summary

      The current URGN market cap is 612.04M. The company's latest EPS is USD -2.8299 and P/E is -5.99.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 17.19M21.14M20.85M23.53M18.78M
      Operating Income -22.05M-15.38M-13.5M-14.61M-25.74M
      Net Income -30.21M-24.14M-21.88M-26.02M-32.29M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 18k11.8M48.04M64.36M82.71M
      Operating Income -109.48M-126.74M-92.29M-79.04M-65.54M
      Net Income -105.15M-128.48M-110.82M-109.78M-102.24M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 112.95M95.36M193.63M178.31M200.57M
      Total Liabilities 229.51M233.8M235.63M243.52M240.71M
      Total Equity -116.55M-138.43M-41.99M-65.21M-40.13M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 202.39M122.01M119.75M135.62M178.31M
      Total Liabilities 22.09M25.65M111.33M224.98M243.52M
      Total Equity 180.3M96.36M8.41M-89.36M-65.21M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -25.81M-46.08M-63.38M-76.38M-31.74M
      Investing 6.27M9.99M10.39M-953k13.52M
      Financing 671k814k116.89M116.93M54.66M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -71.02M-105.89M-84.89M-87.56M-76.38M
      Investing -145.59M93.24M4.07M1.06M-953k
      Financing 165.25M16.53M72.32M97.13M116.93M

      Stats and Ratios

      Market Cap 612.04M
      Price to Earnings Ratio -5.99
      Price to Sales Ratio 7.4
      Price to Cash Ratio 6.44
      Price to Book Ratio -9.39
      Dividend Yield -

      Share Statistics

      Shares Outstanding 36.13M
      Average Volume (1 week) 463.2k
      Average Volume (1 Month) 475.18k
      52 Week Change 75.73%
      52 Week High 24.13
      52 Week Low 8.69
      Spread (Intraday) 0.66 (3.84%)

      Company Info

      Company Name UroGen Pharma Ltd
      Address 9 hataasiya st
      ra'anana, center 4365007
      Website https://www.urogen.com
      Industry pharmaceutical preparations (2834)